The European Food Safety Authority (Efsa) has denied that it is waiting for the outcome of research on the safety of CBD by its US counterpart, the Food and Drug Administration (FDA), before it lets validated candidates complete the novel food application process.

Efsa denied claims by one of the validated applicants in the process, which said the agency had advised it not to proceed with the toxicological studies it had required CBD firms to produce until the FDA published its own safety data.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us